1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Disease

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Coronary Disease in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (33.33)	18.7374
1990's	21 (43.75)	18.2507
2000's	7 (14.58)	29.6817
2010's	4 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
CHEN, KJ; XUE, M; YIN, HJ	1
Chen, H; Eberhard, J; El Mokhtari, NE; Jepsen, S; Lins, M; Zhao, L; Zheng, P; Zhu, H; Zhu, J	1
Feng, W; Liu, XL; Sun, QF; Wu, T; Yang, PS	1
Chen, HY; Chu, JF; Mei, LJ; Wang, T; Xiong, SQ; Zheng, GH	1
Dong, CM; Jia, XQ; Qin, J; Zhang, L	1
Budaj, A; Copland, I; Eikelboom, JW; Johnston, M; Maciejewski, P; Weitz, JI; Yusuf, S; Zhao, F	1
Gruska, S; Jendral, I; Kraatz, G; Rettig, R	1
Cao, HC; Chen, XM; Xu, ZR; Yang, YM	1
Holmes, CE; Madsen, NJ; Schneider, DJ; Serrano, FA; Sobel, BE	1
Cui, K; Gaskell, SJ; Haught, CA; Johnston, DA; McNatt, JM; Mueller, HW; Willerson, JT	1
Evangelou, AM	1
Goudevenos, J; Grekas, G; Kritikakos, J; Sideris, D; Tselepis, AD; Tsoukatos, D	1
Elizarova, EP	1
Backer, CL; Crawford, SE; Gonzalez-Crussi, F; Hsueh, W; Huang, L; Liu, H; Mavroudis, C; Mu, Y; Takami, H	1
Fukuda, N; Ito, S; Soeki, T; Tamura, Y	1
Adamides, K; Goudevenos, JA; Katsouras, CS; Kolettis, T; Michalis, LK; Sideris, DA; Tambaki, AP; Tselepis, AD	1
Kübler, W; Neumann, FJ; Ott, I; Rauch, B; Richardt, G; Tillmanns, H; Zimmermann, R	1
Graham, RM; Stephens, CJ; Sturm, MJ; Taylor, RR	1
Graham, RM; Leong, LL; Stephens, CJ; Sturm, MJ; Taylor, RR; Yadava, OP	1
Leong, LL; Papadimitriou, JM; Stephens, CJ; Sturm, MJ; Taylor, RR	1
Krantz, S; Lefer, AM; Ma, XL; Weyrich, AS	1
Leong, LL; Stephens, CJ; Sturm, MJ; Taylor, RR	1
Alloatti, G; Camussi, G; Emanuelli, G; Montrucchio, G	1
Braquet, C; Köpernik, W; Mest, HJ; Rein, T; Riedel, A	1
Leong, L; Sturm, M; Taylor, R	1
Berti, F; De Angelis, L; Galli, G; Magni, F; Rossoni, G	1
Braquet, P; Esanu, A; Hosford, D; Koltai, M; Tosaki, A	1
Flores, NA; Seghatchian, MJ; Sheridan, DJ	1
Yanoshita, R	1
Bochkov, VN; Bochkova, NA; Kukharchuk, VV; Lyakishev, AA; Rozhkova, TA; Tkachuk, VA	1
Flores, NA; Sheridan, DJ	1
Collins, PD; Tannière-Zeller, M; Williams, FM; Williams, TJ	1
Bigaud, M; Parratt, JR; Wainwright, CL	2
Alloatti, G; Camussi, G; De Luca, R; Emanuelli, G; Montrucchio, G; Saunders, RN; Tetta, C	1
Lefer, AM	1
Joseph, R; Welch, KM	1
Kraemer, R; Mullane, KM; Westlin, W	1
Brusca, A; Camussi, G; Emanuelli, G; Libero, L; Montrucchio, G; Orzan, F; Tetta, C	1
Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT	1
Gateau, O	1
Bugriĭ, EM; Karpov, IuA; Kiktev, VG; Kuz'min, AV; Men'shikov, MIu	1
Lefer, AM; Stahl, GL; Terashita, Z	1
Peskar, BA; Simmet, T	1
Homeister, JW; Jackson, CV; Lucchesi, BR; Mickelson, JK	1
Ezra, D; Feuerstein, GZ; Goldstein, RE; Laurindo, FR	1
Gratsianskiĭ, NA; Men'shikov, MIu; Panchenko, EP; Shalaev, SV; Tkachuk, VA	1
de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F	1

Reviews

5 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Disease

Article	Year
Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 50, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Blood Vessels; Coronary Disease; Cytokines; Endothelium, Vascular; Humans; Phospholipases A; Platelet Activating Factor; Vascular Diseases; Vasculitis	1994
Platelet activating factor (PAF) and its role in cardiac injury. Progress in clinical and biological research, 1989, Volume: 301 Topics: Animals; Coronary Disease; Heart; Heart Diseases; Platelet Activating Factor	1989
Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Annals of the New York Academy of Sciences, 1988, Volume: 524 Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cardiomyopathies; Coronary Disease; Eicosanoic Acids; Free Radicals; Humans; Lipoxygenase; Neutrophils; Oxygen; Platelet Activating Factor; Platelet Aggregation; Serotonin; SRS-A; Superoxides	1988
Eicosanoids and the coronary circulation. Reviews of physiology, biochemistry and pharmacology, 1986, Volume: 104 Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes	1986
Interaction of the formed elements of blood with the coronary vasculature in vivo. Federation proceedings, 1987, Volume: 46, Issue:1 Topics: Animals; Blood Cells; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dogs; Endothelium; Free Radicals; Leukocytes; Oxygen; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Vasodilation; Xanthine Oxidase	1987

Trials

3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Disease

Article	Year
[Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2012, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Prospective Studies; Ticlopidine; Tissue Plasminogen Activator; von Willebrand Factor	2012
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. European heart journal, 2002, Volume: 23, Issue:22 Topics: Antigens; Aspirin; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Clopidogrel; Cohort Studies; Coronary Disease; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; von Willebrand Factor	2002
Effect of gallopamil on neutrophil function: experimental and clinical studies. Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 7 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Gallopamil; Humans; In Vitro Techniques; Neutrophils; Platelet Activating Factor; Superoxides; Tetradecanoylphorbol Acetate	1992

Other Studies

40 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Disease

Article	Year
Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome. Chinese journal of integrative medicine, 2008, Volume: 14, Issue:4 Topics: Coronary Disease; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; P-Selectin; Platelet Activating Factor; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex	2008
Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clinical oral investigations, 2010, Volume: 14, Issue:6 Topics: Adult; Alveolar Bone Loss; Coronary Disease; Dental Plaque Index; Female; Gingival Crevicular Fluid; Gingival Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Platelet Activating Factor; Sulfides; Young Adult	2010
[Detection of platelet-activating factor in unstimulated mixed saliva and gingival crevicular fluid of periodontitis patients with coronary heart disease]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2010, Volume: 19, Issue:3 Topics: Aged; Blood Platelets; Coronary Disease; Gingival Crevicular Fluid; Humans; Periodontal Pocket; Periodontitis; Platelet Activating Factor; Risk Factors; Saliva	2010
Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case control study: a case-control study. Inflammation, 2012, Volume: 35, Issue:4 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; C-Reactive Protein; Case-Control Studies; China; Coronary Disease; Female; Humans; Interleukin-6; Male; Middle Aged; Platelet Activating Factor; Risk Factors; Surveys and Questionnaires	2012
Sodium/lithium countertransport and intracellular calcium concentration in patients with essential hypertension and coronary heart disease. Clinical science (London, England : 1979), 2003, Volume: 104, Issue:3 Topics: Aged; Antiporters; B-Lymphocytes; Calcium; Cell Transformation, Viral; Cells, Cultured; Coronary Disease; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Platelet Activating Factor; Regression Analysis; Signal Transduction	2003
Creation of reversed phase high-performance liquid chromatographic technique to assay platelet-activating factor. Journal of Zhejiang University. Science, 2004, Volume: 5, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebral Infarction; Chromatography, High Pressure Liquid; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Reproducibility of Results; Sensitivity and Specificity	2004
Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents. The American journal of cardiology, 2007, Aug-15, Volume: 100, Issue:4 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Benzothiazoles; Blood Platelets; Coronary Disease; Crotalid Venoms; Flow Cytometry; Fluorescent Dyes; Hemostatics; Humans; Lectins, C-Type; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Quinolines; Thrombin; Tirofiban; Tyrosine	2007
Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circulation research, 1995, Volume: 77, Issue:1 Topics: Animals; Biological Assay; Chromatography, Gas; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dogs; Endarterectomy; Humans; In Vitro Techniques; Male; Mass Spectrometry; Platelet Activating Factor; Rabbits; Radioimmunoassay; Time Factors	1995
Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease. European heart journal, 1995, Volume: 16, Issue:8 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Coronary Disease; Exercise; Humans; Lipids; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Aggregation	1995
Effects of taurine on calcium in platelets and their aggregation. Advances in experimental medicine and biology, 1996, Volume: 403 Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Coronary Disease; Cytosol; Female; Humans; Hypertension; In Vitro Techniques; Kinetics; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Taurine	1996
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Captopril; Coronary Disease; Disease Models, Animal; Drug Therapy, Combination; Heart Transplantation; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Treatment Outcome; Triazoles; Ventricular Remodeling	1999
Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. Japanese circulation journal, 2000, Volume: 64, Issue:8 Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cohort Studies; Coronary Disease; Female; Fibrinolysin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Platelet Factor 4; Time Factors; Tissue Plasminogen Activator	2000
Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes. Current medical research and opinion, 2002, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Electrocardiography; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Sensitivity and Specificity; Syndrome	2002
Plasma platelet-activating factor degradation in patients with severe coronary artery disease. Clinical science (London, England : 1979), 1992, Volume: 82, Issue:5 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cholesterol; Cholesterol, LDL; Coronary Disease; Half-Life; Humans; Male; Middle Aged; Phospholipases A; Platelet Activating Factor	1992
Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. Cardiovascular research, 1992, Volume: 26, Issue:1 Topics: Carboxylic Ester Hydrolases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Bypass; Coronary Disease; Half-Life; Humans; Lipids; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Postoperative Period	1992
The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog. Journal of molecular and cellular cardiology, 1992, Volume: 24, Issue:6 Topics: Animals; Arrhythmias, Cardiac; Azepines; Coronary Disease; Dogs; Myocardial Reperfusion Injury; Platelet Activating Factor; Tachycardia; Triazoles; Ventricular Fibrillation	1992
Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:3 Topics: Animals; Azepines; Cats; Cell Adhesion; Coronary Disease; Creatine Kinase; Endothelium, Vascular; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Triazoles	1992
Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog. Cardiovascular research, 1992, Volume: 26, Issue:2 Topics: Animals; Azepines; Cardiac Output; Coronary Disease; Disease Models, Animal; Dogs; Myocardial Infarction; Myocardium; Platelet Activating Factor; Regional Blood Flow; Triazoles	1992
Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. Journal of molecular and cellular cardiology, 1992, Volume: 24, Issue:2 Topics: Animals; Blood Platelets; Cell Communication; Coronary Circulation; Coronary Disease; Heart; In Vitro Techniques; Myocardial Reperfusion; Neutrophils; Platelet Activating Factor; Rabbits; Ventricular Function, Left	1992
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. Agents and actions. Supplements, 1992, Volume: 37 Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Azepines; Clemastine; Coronary Disease; Coronary Vessels; Guinea Pigs; Organoselenium Compounds; Ouabain; Piperidines; Platelet Activating Factor; Propranolol; Rats; Triazoles; Umbelliferones; Ventricular Fibrillation	1992
The lyso-precursor of platelet-activating factor (lyso-PAF) in ischaemic myocardium. Journal of lipid mediators, 1991, Volume: 4, Issue:3 Topics: Acetylation; Animals; Arachidonic Acid; Blood Platelets; Coronary Disease; Dogs; Kinetics; Myocardium; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Serotonin; Type C Phospholipases	1991
Opposite effects of PGI2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart. Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21B Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Myocardial Reperfusion Injury; Platelet Activating Factor; Polydeoxyribonucleotides; Rabbits	1991
Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts. Cardiovascular research, 1991, Volume: 25, Issue:5 Topics: Animals; Arrhythmias, Cardiac; Azepines; Coronary Disease; Dose-Response Relationship, Drug; Heart; Heart Ventricles; Male; Myocardial Reperfusion; Organ Culture Techniques; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles	1991
Platelet-mediated alterations in cardiac cellular electrophysiology. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1991, Volume: 2, Issue:2 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Blood Platelets; Coronary Disease; Electrophysiology; Guinea Pigs; Heart; Male; Platelet Activating Factor; Platelet Activation	1991
[Phospholipid alteration and activation of phospholipase A2 in ischemic heart]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1991, Volume: 36, Issue:3 Topics: Animals; Coronary Disease; Myocardial Reperfusion Injury; Myocardium; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Rats; Swine	1991
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thrombosis research, 1991, Feb-15, Volume: 61, Issue:4 Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Coronary Disease; Cytosol; Epinephrine; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Platelet Activating Factor	1991
Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. British journal of pharmacology, 1990, Volume: 101, Issue:3 Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Perfusion; Platelet Activating Factor; Ventricular Fibrillation	1990
The relationship between neutrophils and increased microvascular permeability in a model of myocardial ischaemia and reperfusion in the rabbit. British journal of pharmacology, 1990, Volume: 100, Issue:4 Topics: Anesthesia; Animals; Antibodies, Monoclonal; Azepines; Blood Pressure; Blood Proteins; Capillary Permeability; Coronary Disease; Heart Rate; In Vitro Techniques; Indium Radioisotopes; Iodine Radioisotopes; Male; Mechlorethamine; Models, Biological; Myocardial Reperfusion Injury; Neutrophils; Platelet Activating Factor; Rabbits; Triazoles	1990
The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. European heart journal, 1989, Volume: 10, Issue:3 Topics: Acute Disease; Animals; Blood Gas Analysis; Cardiac Complexes, Premature; Coronary Disease; Disease Models, Animal; Diterpenes; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Ginkgolides; Hemodynamics; Hydrogen-Ion Concentration; Lactones; Myocardial Reperfusion; Oxygen; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Random Allocation; Tachycardia; Time Factors; Ventricular Fibrillation	1989
Release of platelet-activating factor from ischemic-reperfused rabbit heart. The American journal of physiology, 1989, Volume: 256, Issue:4 Pt 2 Topics: Animals; Coronary Disease; Myocardial Reperfusion; Myocardium; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolines; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled	1989
Granulocytes, platelet-activating factor, and myocardial injury. Circulation, 1989, Volume: 79, Issue:6 Topics: Animals; Coronary Disease; Granulocytes; Papio; Platelet Activating Factor	1989
Intravascular release of platelet-activating factor during atrial pacing. Lancet (London, England), 1986, Aug-02, Volume: 2, Issue:8501 Topics: Adult; Cardiac Pacing, Artificial; Coronary Disease; Humans; Male; Middle Aged; Platelet Activating Factor	1986
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. Circulation, 1985, Volume: 72, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2	1985
[Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80 Spec No Topics: Coronary Disease; Humans; Platelet Activating Factor; Platelet Aggregation	1987
[Calcium metabolism of the thrombocytes in ischemic heart disease]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1988, Volume: 11, Issue:2 Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Calcium; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors	1988
The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. Biomedica biochimica acta, 1988, Volume: 47, Issue:10-11 Topics: Animals; Coronary Disease; Diterpenes; Dogs; Female; Ginkgolides; Heart; Lactones; Male; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Quinolinium Compounds	1988
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3 Topics: Animals; Blood Pressure; Capillary Permeability; Coronary Disease; Heart; Heart Rate; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains	1988
Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. Pharmacological research communications, 1986, Volume: 18 Suppl Topics: Coronary Circulation; Coronary Disease; Humans; Platelet Activating Factor; Pulmonary Circulation; SRS-A; Vasodilator Agents	1986
[Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1986, Volume: 9, Issue:2 Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Calcium; Coronary Artery Disease; Coronary Disease; Cytoplasm; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Serotonin	1986
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. Thrombosis research, 1985, Aug-15, Volume: 39, Issue:4 Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2	1985